Cargando…

The Natural History Model of Hepatitis C Virus Infection and the Economic Evaluation of Alpha Interferon Treatment

Interferon (IFN) therapy is used for the treatment of hepatitis C virus (HCV) disease, but is so expensive that it creates controversy as to whether or not it is effective use of limited health care resources. In order to make this judgement possible, it must be necessary to build a comprehensive di...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hayashida, Kenshi, Nagasue, Ichiro, Fukuda, Takashi, Gunji, Atsuaki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Japan Epidemiological Association 2007
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10432253/ https://www.ncbi.nlm.nih.gov/pubmed/11848181 http://dx.doi.org/10.2188/jea.12.22

Ejemplares similares

Galectin-9 and Interferon-Gamma Are Released by Natural Killer Cells upon Activation with Interferon-Alpha and Orchestrate the Suppression of Hepatitis C Virus Infection
por: Carreca, Anna Paola, et al.
Publicado: (2022)

Natural history and treatment of hepatitis B virus and hepatitis C virus coinfection
por: Crockett, Seth D, et al.
Publicado: (2005)

The Natural History of Hepatitis C Virus (HCV) Infection
por: Chen, Stephen L., et al.
Publicado: (2006)

Transcriptional response to hepatitis C virus infection and interferon‐alpha treatment in the human liver
por: Boldanova, Tujana, et al.
Publicado: (2017)

Pegylated Interferon Alpha for Chronic Hepatitis B Virus Infection
por: Vasconcelos, Joana, et al.
Publicado: (2022)

Differential expression of interferon-induced microRNAs in patients with chronic hepatitis C virus infection treated with pegylated interferon alpha
por: Scagnolari, Carolina, et al.
Publicado: (2010)

Strain-specific responsiveness of hepatitis D virus to interferon-alpha treatment
por: Giersch, Katja, et al.
Publicado: (2023)

The natural history of interferon-α induced thyroiditis in chronic hepatitis c patients: a long term study
por: Tran, Huy A, et al.
Publicado: (2011)

Interferon Alpha Induces Cellular Autophagy and Modulates Hepatitis B Virus Replication
por: Li, Jia, et al.
Publicado: (2022)

Interferon-alpha responsible EPN3 regulates hepatitis B virus replication
por: Li, Xueqian, et al.
Publicado: (2022)

Interferon alpha treatment stimulates interferon gamma expression in type I NKT cells and enhances their antiviral effect against hepatitis C virus
por: Miyaki, Eisuke, et al.
Publicado: (2017)

Hepatitis C Virus Clearance after Discontinuation of Pegylated Interferon Alpha-2a Monotherapy in a Child
por: Endo, Takeshi, et al.
Publicado: (2012)

Intrinsic Viral Factors Are the Dominant Determinants of the Hepatitis C Virus Response to Interferon Alpha Treatment in Chimeric Mice
por: Chen, Ran, et al.
Publicado: (2016)

Development of latent Interferon alpha 2b as a safe therapeutic for treatment of Hepatitis C virus infection
por: Gull, Iram, et al.
Publicado: (2019)

Thyroid hormonal disturbances related to treatment of hepatitis C with interferon-alpha and ribavirin
por: Danilovic, Debora Lucia Seguro, et al.
Publicado: (2011)

Irreversible Pulmonary Hypertension Associated with the use of Interferon Alpha for Chronic Hepatitis C
por: Dhillon, Sonu, et al.
Publicado: (2010)

Interferon-alpha-induced sarcoidosis in a patient being treated for hepatitis C
por: Trien, Remi, et al.
Publicado: (2014)

Interferon sensitivity-determining region of hepatitis C virus influences virus production and interferon signaling
por: Sugiyama, Ryuichi, et al.
Publicado: (2017)

Interferon-alpha treatment rapidly clears Hepatitis E virus infection in humanized mice
por: van de Garde, Martijn D. B., et al.
Publicado: (2017)

Negative Regulation of Hepatitis C Virus Specific Immunity Is Highly Heterogeneous and Modulated by Pegylated Interferon-Alpha/Ribavirin Therapy
por: Claassen, Mark A. A., et al.
Publicado: (2012)

Exosomal Interferon‐Induced Transmembrane Protein 2 Transmitted to Dendritic Cells Inhibits Interferon Alpha Pathway Activation and Blocks Anti–Hepatitis B Virus Efficacy of Exogenous Interferon Alpha
por: Shi, Ying, et al.
Publicado: (2019)

Type III Interferons in Hepatitis C Virus Infection
por: Boisvert, Maude, et al.
Publicado: (2016)

Association of chronic hepatitis C with major depressive disorders: irrespective of interferon-alpha therapy
por: Carta, Mauro G, et al.
Publicado: (2007)

Nanomedicines in the treatment of chronic hepatitis C – focus on pegylated interferon alpha-2a
por: Thomas, Thea, et al.
Publicado: (2007)

Interferon-Alpha Induced and Ribavirin Induced Thyroid Dysfunction in Patients with Chronic Hepatitis C
por: Nadeem, Amina, et al.
Publicado: (2010)

Hepatocellular carcinoma or interferon-based therapy history attenuates sofosbuvir/ribavirin for Japanese genotype 2 hepatitis C virus
por: Yada, Masayoshi, et al.
Publicado: (2018)

Serum interferon alpha receptor 2 mRNA may predict efficacy of interferon alpha with/without low-dose sorafenib for metastatic clear cell renal cell carcinoma
por: Furuya, Nobutaka, et al.
Publicado: (2011)

Pegylated Interferon and Ribavirin Treatment for Hepatitis C Virus Infection
por: Kagawa, Tatehiro, et al.
Publicado: (2010)

Retinopathy associated with interferon therapy in patients with hepatitis C virus
por: Abd El-Badie Mohamed, Mahmoud, et al.
Publicado: (2012)

Hepatitis C Virus Infection: Looking for Interferon Free Regimens
por: González-Moreno, J., et al.
Publicado: (2013)

Interferon-Induced Effector Proteins and Hepatitis C Virus Replication
por: Frese, Michael, et al.
Publicado: (2008)

Nanomedicines in the treatment of patients with hepatitis C co-infected with HIV – focus on pegylated interferon-alpha
por: Zoller, Heinz, et al.
Publicado: (2006)

Cystoid macular edema and visual loss as sequelae to interferon alpha treatment of systemic hepatitis C
por: Sheth, Hiten G, et al.
Publicado: (2010)

Acute pancreatitis associated with pegylated interferon-alpha-2a therapy in chronic hepatitis C
por: Choi, Jong Wook, et al.
Publicado: (2016)

Thyroid disturbances in children treated with combined pegylated interferon-alpha and ribavirin for chronic hepatitis C
por: Rashed, Yasser K., et al.
Publicado: (2020)

Clinical features and natural history of cryptogenic cirrhosis compared to hepatitis C virus-related cirrhosis
por: Rinaldi, Luca, et al.
Publicado: (2017)

Interferon Alpha-2b Therapy in Chronic Hepatitis Delta
por: Keshvari, Maryam, et al.
Publicado: (2014)

Consensus on Pegylated Interferon Alpha in Treatment of Chronic Hepatitis B
por: Zhang, Wenhong, et al.
Publicado: (2018)

Natural History and Clinical Consequences of Hepatitis B Virus Infection
por: Pan, Calvin Q., et al.
Publicado: (2005)

STAT1 is essential for the inhibition of hepatitis C virus replication by interferon-λ but not by interferon-α
por: Yamauchi, Shota, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_hnofg7ojgvliu6sc5nvc5ir0av